NCT02011763View on ClinicalTrials.gov

Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and Adolescents

PHASE4CompletedINTERVENTIONAL

Enrollment

355

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

August 31, 2015

Conditions

Hepatitis AHepatitis A Virus

Interventions

BIOLOGICAL

Avaxim 80U Pediatric: Inactivated Hepatitis A Virus

0.5 mL, Intramuscular (2 injection 6 months apart)

Trial Locations (1)

100021

Beijing

All Listed Sponsors

lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT02011763 - Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and Adolescents | Biotech Hunter | Biotech Hunter